Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)
申请人:Shapiro Paul S.
公开号:US09115122B2
公开(公告)日:2015-08-25
A compound, having the formula A-1:
Wherein R1 and R2 are defined herein. Methods of using the compound and compositions containing the compound are provided.
The present disclosure provides methods of treating a hepatitis C virus infection. The methods generally involve administering to an individual in need thereof an effective amount of an active agent that inhibits a RAS-RAF-MEK-ERK signal transduction pathway.